 | • レポートコード：QFJ1-5600 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、アルテスネイト薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単芳香族アルテスネート、複合アルテスネート）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アルテスネイト薬の市場動向 ・企業の競争状況、市場シェア ・アルテスネイト薬の種類別市場規模と予測2016-2027（単芳香族アルテスネート、複合アルテスネート） ・アルテスネイト薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・アルテスネイト薬の北米市場規模2016-2027（アメリカ、カナダ） ・アルテスネイト薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アルテスネイト薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アルテスネイト薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・アルテスネイト薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Fosun Pharma (Guilin)、Ipca Laboratories、Sanofi Aventis、Ajanta Pharma、Shin Poong、Cipla、Acino、MCW Healthcare） ・結論 |
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
Market Analysis and Insights: Global Artesunate Medicines Market
The global Artesunate Medicines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Artesunate Medicines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Artesunate Medicines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artesunate Medicines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artesunate Medicines market.
Global Artesunate Medicines Scope and Market Size
Artesunate Medicines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Artesunate Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artesunate Medicines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoaromatic Artesunate
1.2.3 Compound Artesunate
1.3 Market by Application
1.3.1 Global Artesunate Medicines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Artesunate Medicines Market Perspective (2016-2027)
2.2 Artesunate Medicines Growth Trends by Regions
2.2.1 Artesunate Medicines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Artesunate Medicines Historic Market Share by Regions (2016-2021)
2.2.3 Artesunate Medicines Forecasted Market Size by Regions (2022-2027)
2.3 Artesunate Medicines Industry Dynamic
2.3.1 Artesunate Medicines Market Trends
2.3.2 Artesunate Medicines Market Drivers
2.3.3 Artesunate Medicines Market Challenges
2.3.4 Artesunate Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artesunate Medicines Players by Revenue
3.1.1 Global Top Artesunate Medicines Players by Revenue (2016-2021)
3.1.2 Global Artesunate Medicines Revenue Market Share by Players (2016-2021)
3.2 Global Artesunate Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Artesunate Medicines Revenue
3.4 Global Artesunate Medicines Market Concentration Ratio
3.4.1 Global Artesunate Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artesunate Medicines Revenue in 2020
3.5 Artesunate Medicines Key Players Head office and Area Served
3.6 Key Players Artesunate Medicines Product Solution and Service
3.7 Date of Enter into Artesunate Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artesunate Medicines Breakdown Data by Type
4.1 Global Artesunate Medicines Historic Market Size by Type (2016-2021)
4.2 Global Artesunate Medicines Forecasted Market Size by Type (2022-2027)
5 Artesunate Medicines Breakdown Data by Application
5.1 Global Artesunate Medicines Historic Market Size by Application (2016-2021)
5.2 Global Artesunate Medicines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Artesunate Medicines Market Size (2016-2027)
6.2 North America Artesunate Medicines Market Size by Type
6.2.1 North America Artesunate Medicines Market Size by Type (2016-2021)
6.2.2 North America Artesunate Medicines Market Size by Type (2022-2027)
6.2.3 North America Artesunate Medicines Market Size by Type (2016-2027)
6.3 North America Artesunate Medicines Market Size by Application
6.3.1 North America Artesunate Medicines Market Size by Application (2016-2021)
6.3.2 North America Artesunate Medicines Market Size by Application (2022-2027)
6.3.3 North America Artesunate Medicines Market Size by Application (2016-2027)
6.4 North America Artesunate Medicines Market Size by Country
6.4.1 North America Artesunate Medicines Market Size by Country (2016-2021)
6.4.2 North America Artesunate Medicines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Artesunate Medicines Market Size (2016-2027)
7.2 Europe Artesunate Medicines Market Size by Type
7.2.1 Europe Artesunate Medicines Market Size by Type (2016-2021)
7.2.2 Europe Artesunate Medicines Market Size by Type (2022-2027)
7.2.3 Europe Artesunate Medicines Market Size by Type (2016-2027)
7.3 Europe Artesunate Medicines Market Size by Application
7.3.1 Europe Artesunate Medicines Market Size by Application (2016-2021)
7.3.2 Europe Artesunate Medicines Market Size by Application (2022-2027)
7.3.3 Europe Artesunate Medicines Market Size by Application (2016-2027)
7.4 Europe Artesunate Medicines Market Size by Country
7.4.1 Europe Artesunate Medicines Market Size by Country (2016-2021)
7.4.2 Europe Artesunate Medicines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Artesunate Medicines Market Size (2016-2027)
8.2 Asia-Pacific Artesunate Medicines Market Size by Type
8.2.1 Asia-Pacific Artesunate Medicines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Artesunate Medicines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Artesunate Medicines Market Size by Type (2016-2027)
8.3 Asia-Pacific Artesunate Medicines Market Size by Application
8.3.1 Asia-Pacific Artesunate Medicines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Artesunate Medicines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Artesunate Medicines Market Size by Application (2016-2027)
8.4 Asia-Pacific Artesunate Medicines Market Size by Region
8.4.1 Asia-Pacific Artesunate Medicines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Artesunate Medicines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Artesunate Medicines Market Size (2016-2027)
9.2 Latin America Artesunate Medicines Market Size by Type
9.2.1 Latin America Artesunate Medicines Market Size by Type (2016-2021)
9.2.2 Latin America Artesunate Medicines Market Size by Type (2022-2027)
9.2.3 Latin America Artesunate Medicines Market Size by Type (2016-2027)
9.3 Latin America Artesunate Medicines Market Size by Application
9.3.1 Latin America Artesunate Medicines Market Size by Application (2016-2021)
9.3.2 Latin America Artesunate Medicines Market Size by Application (2022-2027)
9.3.3 Latin America Artesunate Medicines Market Size by Application (2016-2027)
9.4 Latin America Artesunate Medicines Market Size by Country
9.4.1 Latin America Artesunate Medicines Market Size by Country (2016-2021)
9.4.2 Latin America Artesunate Medicines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artesunate Medicines Market Size (2016-2027)
10.2 Middle East & Africa Artesunate Medicines Market Size by Type
10.2.1 Middle East & Africa Artesunate Medicines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Artesunate Medicines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Artesunate Medicines Market Size by Type (2016-2027)
10.3 Middle East & Africa Artesunate Medicines Market Size by Application
10.3.1 Middle East & Africa Artesunate Medicines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Artesunate Medicines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Artesunate Medicines Market Size by Application (2016-2027)
10.4 Middle East & Africa Artesunate Medicines Market Size by Country
10.4.1 Middle East & Africa Artesunate Medicines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Artesunate Medicines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Fosun Pharma (Guilin)
11.1.1 Fosun Pharma (Guilin) Company Details
11.1.2 Fosun Pharma (Guilin) Business Overview
11.1.3 Fosun Pharma (Guilin) Artesunate Medicines Introduction
11.1.4 Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2016-2021)
11.1.5 Fosun Pharma (Guilin) Recent Development
11.2 Ipca Laboratories
11.2.1 Ipca Laboratories Company Details
11.2.2 Ipca Laboratories Business Overview
11.2.3 Ipca Laboratories Artesunate Medicines Introduction
11.2.4 Ipca Laboratories Revenue in Artesunate Medicines Business (2016-2021)
11.2.5 Ipca Laboratories Recent Development
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Details
11.3.2 Sanofi Aventis Business Overview
11.3.3 Sanofi Aventis Artesunate Medicines Introduction
11.3.4 Sanofi Aventis Revenue in Artesunate Medicines Business (2016-2021)
11.3.5 Sanofi Aventis Recent Development
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Details
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Artesunate Medicines Introduction
11.4.4 Ajanta Pharma Revenue in Artesunate Medicines Business (2016-2021)
11.4.5 Ajanta Pharma Recent Development
11.5 Shin Poong
11.5.1 Shin Poong Company Details
11.5.2 Shin Poong Business Overview
11.5.3 Shin Poong Artesunate Medicines Introduction
11.5.4 Shin Poong Revenue in Artesunate Medicines Business (2016-2021)
11.5.5 Shin Poong Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Artesunate Medicines Introduction
11.6.4 Cipla Revenue in Artesunate Medicines Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Acino
11.7.1 Acino Company Details
11.7.2 Acino Business Overview
11.7.3 Acino Artesunate Medicines Introduction
11.7.4 Acino Revenue in Artesunate Medicines Business (2016-2021)
11.7.5 Acino Recent Development
11.8 MCW Healthcare
11.8.1 MCW Healthcare Company Details
11.8.2 MCW Healthcare Business Overview
11.8.3 MCW Healthcare Artesunate Medicines Introduction
11.8.4 MCW Healthcare Revenue in Artesunate Medicines Business (2016-2021)
11.8.5 MCW Healthcare Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Artesunate Medicines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoaromatic Artesunate
Table 3. Key Players of Compound Artesunate
Table 4. Global Artesunate Medicines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Artesunate Medicines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Artesunate Medicines Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Artesunate Medicines Market Share by Regions (2016-2021)
Table 8. Global Artesunate Medicines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Artesunate Medicines Market Share by Regions (2022-2027)
Table 10. Artesunate Medicines Market Trends
Table 11. Artesunate Medicines Market Drivers
Table 12. Artesunate Medicines Market Challenges
Table 13. Artesunate Medicines Market Restraints
Table 14. Global Artesunate Medicines Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Artesunate Medicines Market Share by Players (2016-2021)
Table 16. Global Top Artesunate Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artesunate Medicines as of 2020)
Table 17. Ranking of Global Top Artesunate Medicines Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Artesunate Medicines Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Artesunate Medicines Product Solution and Service
Table 21. Date of Enter into Artesunate Medicines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artesunate Medicines Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Artesunate Medicines Revenue Market Share by Type (2016-2021)
Table 25. Global Artesunate Medicines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Artesunate Medicines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Artesunate Medicines Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Artesunate Medicines Revenue Market Share by Application (2016-2021)
Table 29. Global Artesunate Medicines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Artesunate Medicines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Artesunate Medicines Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Artesunate Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Artesunate Medicines Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Artesunate Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Artesunate Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Artesunate Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Artesunate Medicines Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Artesunate Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Artesunate Medicines Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Artesunate Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Artesunate Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Artesunate Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Artesunate Medicines Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Artesunate Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Artesunate Medicines Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Artesunate Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Artesunate Medicines Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Artesunate Medicines Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Artesunate Medicines Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Artesunate Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Artesunate Medicines Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Artesunate Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Artesunate Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Artesunate Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Artesunate Medicines Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Artesunate Medicines Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Artesunate Medicines Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Artesunate Medicines Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Artesunate Medicines Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Artesunate Medicines Market Size by Country (2022-2027) & (US$ Million)
Table 61. Fosun Pharma (Guilin) Company Details
Table 62. Fosun Pharma (Guilin) Business Overview
Table 63. Fosun Pharma (Guilin) Artesunate Medicines Product
Table 64. Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2016-2021) & (US$ Million)
Table 65. Fosun Pharma (Guilin) Recent Development
Table 66. Ipca Laboratories Company Details
Table 67. Ipca Laboratories Business Overview
Table 68. Ipca Laboratories Artesunate Medicines Product
Table 69. Ipca Laboratories Revenue in Artesunate Medicines Business (2016-2021) & (US$ Million)
Table 70. Ipca Laboratories Recent Development
Table 71. Sanofi Aventis Company Details
Table 72. Sanofi Aventis Business Overview
Table 73. Sanofi Aventis Artesunate Medicines Product
Table 74. Sanofi Aventis Revenue in Artesunate Medicines Business (2016-2021) & (US$ Million)
Table 75. Sanofi Aventis Recent Development
Table 76. Ajanta Pharma Company Details
Table 77. Ajanta Pharma Business Overview
Table 78. Ajanta Pharma Artesunate Medicines Product
Table 79. Ajanta Pharma Revenue in Artesunate Medicines Business (2016-2021) & (US$ Million)
Table 80. Ajanta Pharma Recent Development
Table 81. Shin Poong Company Details
Table 82. Shin Poong Business Overview
Table 83. Shin Poong Artesunate Medicines Product
Table 84. Shin Poong Revenue in Artesunate Medicines Business (2016-2021) & (US$ Million)
Table 85. Shin Poong Recent Development
Table 86. Cipla Company Details
Table 87. Cipla Business Overview
Table 88. Cipla Artesunate Medicines Product
Table 89. Cipla Revenue in Artesunate Medicines Business (2016-2021) & (US$ Million)
Table 90. Cipla Recent Development
Table 91. Acino Company Details
Table 92. Acino Business Overview
Table 93. Acino Artesunate Medicines Product
Table 94. Acino Revenue in Artesunate Medicines Business (2016-2021) & (US$ Million)
Table 95. Acino Recent Development
Table 96. MCW Healthcare Company Details
Table 97. MCW Healthcare Business Overview
Table 98. MCW Healthcare Revenue in Artesunate Medicines Business (2016-2021) & (US$ Million)
Table 99. MCW Healthcare Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artesunate Medicines Market Share by Type: 2020 VS 2027
Figure 2. Monoaromatic Artesunate Features
Figure 3. Compound Artesunate Features
Figure 4. Global Artesunate Medicines Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Artesunate Medicines Report Years Considered
Figure 9. Global Artesunate Medicines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Artesunate Medicines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Artesunate Medicines Market Share by Regions: 2020 VS 2027
Figure 12. Global Artesunate Medicines Market Share by Regions (2022-2027)
Figure 13. Global Artesunate Medicines Market Share by Players in 2020
Figure 14. Global Top Artesunate Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artesunate Medicines as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Artesunate Medicines Revenue in 2020
Figure 16. Global Artesunate Medicines Revenue Market Share by Type (2016-2021)
Figure 17. Global Artesunate Medicines Revenue Market Share by Type (2022-2027)
Figure 18. North America Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Artesunate Medicines Market Share by Type (2016-2027)
Figure 20. North America Artesunate Medicines Market Share by Application (2016-2027)
Figure 21. North America Artesunate Medicines Market Share by Country (2016-2027)
Figure 22. United States Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Artesunate Medicines Market Share by Type (2016-2027)
Figure 26. Europe Artesunate Medicines Market Share by Application (2016-2027)
Figure 27. Europe Artesunate Medicines Market Share by Country (2016-2027)
Figure 28. Germany Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Artesunate Medicines Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Artesunate Medicines Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Artesunate Medicines Market Share by Region (2016-2027)
Figure 38. China Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Artesunate Medicines Market Share by Type (2016-2027)
Figure 46. Latin America Artesunate Medicines Market Share by Application (2016-2027)
Figure 47. Latin America Artesunate Medicines Market Share by Country (2016-2027)
Figure 48. Mexico Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Artesunate Medicines Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Artesunate Medicines Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Artesunate Medicines Market Share by Country (2016-2027)
Figure 54. Turkey Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Artesunate Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Fosun Pharma (Guilin) Revenue Growth Rate in Artesunate Medicines Business (2016-2021)
Figure 58. Ipca Laboratories Revenue Growth Rate in Artesunate Medicines Business (2016-2021)
Figure 59. Sanofi Aventis Revenue Growth Rate in Artesunate Medicines Business (2016-2021)
Figure 60. Ajanta Pharma Revenue Growth Rate in Artesunate Medicines Business (2016-2021)
Figure 61. Shin Poong Revenue Growth Rate in Artesunate Medicines Business (2016-2021)
Figure 62. Cipla Revenue Growth Rate in Artesunate Medicines Business (2016-2021)
Figure 63. Acino Revenue Growth Rate in Artesunate Medicines Business (2016-2021)
Figure 64. MCW Healthcare Revenue Growth Rate in Artesunate Medicines Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のアルテスネイト薬剤市場規模・現状・予測（2021年-2027年） Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria. Market Analysis and Insights: Global Artesunate Drugs Market The global Artesunate …- アルテスネイト錠剤のグローバル市場2021 Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria. The classification of Artesunate Tablet includes Monoaromatic Artesunate and Compou…
- アーテスネートのグローバル市場調査 2019年 The global Artesunate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Artesunate volume and value at global level, regional level and company level. From a global perspective, this report represents…
- 世界のアルテミシニン併用療法市場規模・現状・予測（2021年-2027年） Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether. Market Analysis and Insights: Global Art…
- 世界の大麻ベース医薬品市場規模・現状・予測（2021年-2027年） Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food…